Malignant melanoma - Interferon alpha: an important option in the therapy of high-risk patients

被引:0
作者
不详
机构
来源
HAUTARZT | 2005年 / 56卷 / 12期
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:1190 / 1190
页数:1
相关论文
共 50 条
[41]   Adjuvant interferon therapy for uveal melanoma patients at high risk of metastasis [J].
Holbrook, A ;
Lane, AM ;
Li, W ;
Gragoudas, ES ;
Egan, KM .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) :S566-S566
[42]   INTRALESIONAL INTERFERON-ALPHA THERAPY IN ADVANCED MALIGNANT-MELANOMA [J].
VONWUSSOW, P ;
BLOCK, B ;
HARTMANN, F ;
DEICHER, H .
CANCER, 1988, 61 (06) :1071-1074
[43]   INTRALESIONAL INTERFERON-ALPHA THERAPY IN ADVANCED MALIGNANT-MELANOMA [J].
VONWUSSOW, P ;
BLOCK, B ;
HARTMANN, F ;
DEICHER, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (04) :584-584
[44]   Update on adjuvant interferon therapy for high-risk melanoma - The Agarwala/Kirkwood article reviewed [J].
Flaherty, K ;
Schuchter, L .
ONCOLOGY-NEW YORK, 2002, 16 (09) :1190-1191
[45]   High-dose interferon versus GM2 vaccine in high-risk malignant melanoma - Reply [J].
Kirkwood, JM ;
Ibrahim, J ;
Manola, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (23) :4350-4350
[46]   ADJUVANT CHEMOTHERAPY IN HIGH-RISK MALIGNANT-MELANOMA [J].
KARAKOUSIS, CP ;
EMRICH, LJ .
CANCER DRUG DELIVERY, 1986, 3 (01) :86-86
[47]   ADJUVANT CHEMOTHERAPY IN HIGH-RISK MALIGNANT-MELANOMA [J].
KARAKOUSIS, CP ;
EMRICH, LJ .
JOURNAL OF SURGICAL ONCOLOGY, 1987, 36 (01) :64-67
[48]   Excision margins in high-risk malignant melanoma - Reply [J].
Thomas, JM ;
A'Hern, R ;
Newton-Bishop, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2306-2306
[49]   MALIGNANT-MELANOMA - IDENTIFICATION OF HIGH-RISK GROUPS [J].
KARDINAL, CG ;
CAROLLA, RL .
MISSOURI MEDICINE, 1976, 73 (12) :666-+
[50]   Adjuvant therapy with high-dose interferon α2b in patients with high-risk stage IIB/III melanoma [J].
Kirkwood, John M. ;
Tarhini, Ahmad A. ;
Moschos, Stergios J. ;
Panelli, Monica C. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (01) :2-3